SCHNITZLER SYNDROME

Clinical trials for SCHNITZLER SYNDROME explained in plain language.

Never miss a new study

Get alerted when new SCHNITZLER SYNDROME trials appear

Sign up with your email to follow new studies for SCHNITZLER SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New study hopes ilaris can tame rare inflammatory disorder

Disease control Not yet recruiting

This study will test the drug Ilaris (canakinumab) in about 5 people with Schnitzler's syndrome, a rare condition that causes hives, fever, joint pain, and fatigue. The goal is to see if Ilaris can reduce or stop these symptoms. Participants will be followed for up to 48 weeks to…

Matched conditions: SCHNITZLER SYNDROME

Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated May 26, 2026 04:29 UTC

SCHNITZLER SYNDROME

Get alerted when new SCHNITZLER SYNDROME trials appear

New study hopes ilaris can tame rare inflammatory disorder